# Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis

> **NCT05809583** · — · WITHDRAWN · sponsor: **Beth Israel Deaconess Medical Center**

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Ozanimod

## Key facts

- **NCT ID:** NCT05809583
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-04-12
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding withdrawn
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05809583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05809583, "Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05809583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*